International Public Tender No. 675/2025 - Acquisition of reagents for chemistry, immunochemistry/serology, hematology/cytology tests of biological fluids, with the placement of automatic pre-analytical, analytical, and post-analytical processing systems and middleware on a loan basis for the Corelab Unit for a period of 84 months

This International Public Tender, reference number 675/2025, is for the acquisition of a comprehensive suite of reagents for various laboratory tests, including chemistry, immunochemistry/serology, and hematology/cytology of biological fluids. A critical component of this tender is the requirement for the supplier to provide and install automatic systems for pre-analytical, analytical, and post-analytical processing, as well as middleware solutions. These advanced systems are to be provided on a loan basis (comodato) to the Corelab Unit for an extended period of 84 months. The objective is to equip the Corelab Unit with state-of-the-art diagnostic capabilities, ensuring efficient, accurate, and high-volume testing. Bidders must demonstrate their capacity to supply both the reagents and the sophisticated automated laboratory equipment, along with robust technical support and maintenance services throughout the 84-month contract period.

This is a supplies contract in the health and medical services and information and communication technology sectors, with a focus on Laboratory, Medical Equipment, digital health systems and Data Analytics. Located in Portugal, Europe, this opportunity is open to firms and consortiums, with an estimated budget of EUR 2.0 million.

Published through base_gov_pt, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.